Membres
Michael White
Responsable de Structure
Responsable
Publications
Télécharger-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 Apr; (): 100275.
-
2021Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study., PLoS Med 2021 Apr; 18(4): e1003535.
-
2021Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients., Antimicrob Agents Chemother 2021 Mar; (): .
-
2021PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon., Pathogens 2021 Mar; 10(3): .
-
2021Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions., Clin Infect Dis 2021 Mar; (): .
-
2021Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis., PLoS Comput Biol 2021 Mar; 17(3): e1008850.
-
2021The top 1%: quantifying the unequal distribution of malaria in Brazil., Malar J 2021 Feb; 20(1): 87.
-
2021Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
-
2021Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts., PLoS Negl Trop Dis 2021 Feb; 15(2): e0009165.
-
2020Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission., Am J Trop Med Hyg 2020 12; 103(6): 2189-2197.
-
+Voir la liste complète de publications